Sacks CA, Lee CC, Kesselheim AS, Avorn J
purchasing cialis online Letter to the FDA Urging Removal of the Cholesterol Lowering Drug Rosuvastatin Crestor From the Market HRG Publication 1698 As you are aware, on March 4th of this year, we petitioned the FDA to ban the recently marketed cholesterol lowering drug rosuvastatin Crestor AstraZeneca because of seven post marketing cases of life threatening rhabdomyolysis and nine cases of renal failure or renal insufficiency